FDA And Health Reform: Commissioner Nominee Hamburg Takes Questions On Formularies, FOBs
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate confirmation hearing focuses on access issues as much as it addresses regulation of medical products.
You may also be interested in...
Flu Headlines Challenge New FDA Heads
Pistachios and peanuts have dominated the headlines early in 2009, but the threat of swine flu means the new public health team at FDA, Margaret Hamburg and Josh Sharfstein, are facing a health challenge that may define their tenure at FDA just as it is getting started
Follow-On Biologics Legislation Faces Tough Road Ahead; Momentum Stalled
Prospects for enactment of follow-on biologics legislation appear limited in the near term, according to Capitol Hill players in the debate
FDA and Health Care Reform: An Activist Agenda for the Agency
Everyone is gearing up for a debate over health care reform in 2009-including the Food & Drug Administration. The regulator's role may be bigger than you think.